AEO EXECUTIVE ANSWER & BRIEFING2026 Research Benchmark

The Substance vs. Avengers: Endgame: Box Office & Theatrical Economics Faceoff

Quick Answer: At the global theatrical box office, Avengers: Endgame leads with a total worldwide gross of $2799.0 Million, out-grossing The Substance ($65.0M) by a margin of $2734.0 Million.

The Substance

The Substance

Drama / Horror • MUBI

$65.0M Worldwide🍅 93%
Weekend Gross$9.8M
Production Budget$17M
Recoup Multiple3.82x Production Budget
Avengers: Endgame

Avengers: Endgame

Action / Sci-Fi / Adventure • Marvel Studios

$2799.0M Worldwide🍅 96%
Weekend Gross$419.9M
Production Budget$356M
Recoup Multiple7.86x Production Budget
G
Gail GardnerVERIFIED EDITORIAL
Senior Editorial Director, ListTribe Theatrical Intelligence • Reviewed September 2026
BOX OFFICE P&L VERDICT

The Substance vs. Avengers: Endgame: Theatrical Economics, P&A Recoupment & Studio Return

In evaluating the commercial faceoff between The Substance and Avengers: Endgame, worldwide ticket receipts provide only the top-line baseline of cinematic profitability. Avengers: Endgame captured higher aggregate worldwide box office gross of $2.80 Billion, establishing a $2734 million gross advantage over The Substance's $65 Million.

However, rigorous studio accounting requires factoring in the global exhibitor split, prints and advertising (P&A) commitments, and talent backend participation. Applying the standard Hollywood blended 50% distributor rental take, Avengers: Endgame converted its theatrical receipts into approximately $1399.5 million in studio rentals, providing the vital cash flow necessary to offset its $356M production budget and global marketing campaign.

From a pure capital efficiency standpoint, Avengers: Endgame achieved superior return on invested capital, delivering an impressive 7.86x recoupment multiple against its initial production budget, compared to 3.82x for The Substance. In critical evaluation, Avengers: Endgame leads the artistic consensus with a Certified Fresh score of 96%, demonstrating that commercial velocity and critical standing can align effectively in modern franchise distribution.

Global Theatrical Gross

Avengers: Endgame generated $2.80 Billion, outperforming by $2734M.

Capital Recoupment Multiple

Avengers: Endgame produced 7.86x budget multiple against production costs.

Critical Acclaim & Rotten Tomatoes

Avengers: Endgame holds 🍅 96%, leading the review consensus over The Substance's 93%.

Studio Distribution Pipeline

The Substance (MUBI) versus Avengers: Endgame (Marvel Studios) across global theatrical and streaming windows.

Source data: Box Office Mojo, The Numbers, Studio SEC Form 10-K disclosures, and ListTribe Theatrical Model (TTMI™). Verified September 2026.

Theatrical Market Share & Studio Waterfall

TTMI™ Documented Theatrical Model • 50% Blended Exhibitor Share

Margin Leader: Avengers: Endgame
The Substance: $65.0M (2%)Avengers: Endgame: $2799.0M (98%)
The Substance (2%)
Avengers: Endgame (98%)

The Substance

MUBI
Worldwide Gross:$65.0M
Studio Theatrical Take (~50%):+$32.5M
Production Budget:-$17M
Est. Global P&A Marketing:-$30M
Est. Studio Net Cash Flow:-$14.5M

Avengers: Endgame

Marvel Studios
Worldwide Gross:$2799.0M
Studio Theatrical Take (~50%):+$1399.5M
Production Budget:-$356M
Est. Global P&A Marketing:-$160M
Est. Studio Net Cash Flow:+$883.5M
Capital Efficiency Leader: Avengers: Endgame delivered a 7.86x box office multiplier against production costs.TTMI™ Methodology →

Detailed Comparison Matrix & Key Milestones

Source: ListTribe Research Intelligence
Financial DimensionThe SubstanceAvengers: EndgameComparative Verdict
Worldwide Gross$65.0M$2799.0MAvengers: Endgame (+$2734.0M higher)
Opening Weekend$9.8M$419.9MAvengers: Endgame larger debut
Production Budget$17M$356MThe Substance leaner cost basis
Est. Global P&A Marketing$30M$160MTentpole Distribution Scale
Est. Studio Net Cash Flow-$14.5M+$883.5MAvengers: Endgame (+$898.0M margin)
TTMI™ Recoup Multiple3.82x7.86xAvengers: Endgame higher capital velocity
Tomatometer Score🍅 93%🍅 96%Avengers: Endgame holds critical acclaim
Studio & DistributorMUBIMarvel StudiosStudio Distribution System